• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型噻唑基肼衍生物作为选择性和可逆性人单胺氧化酶-A抑制剂的设计、合成及生物学评价

Design, synthesis and biological assessment of new thiazolylhydrazine derivatives as selective and reversible hMAO-A inhibitors.

作者信息

Can Nafiz Öncü, Osmaniye Derya, Levent Serkan, Sağlık Begüm Nurpelin, Korkut Büşra, Atlı Özlem, Özkay Yusuf, Kaplancıklı Zafer Asım

机构信息

Department of Analytical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey; Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey.

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey; Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey.

出版信息

Eur J Med Chem. 2018 Jan 20;144:68-81. doi: 10.1016/j.ejmech.2017.12.013. Epub 2017 Dec 6.

DOI:10.1016/j.ejmech.2017.12.013
PMID:29248751
Abstract

In the recent works, it was shown that numerous thiazolylhydrazine derivatives display hMAO inhibitory activity in the range of micromolar concentration. Hence, in the present study a new series of new thiazole-hydrazines (3a-3n) were designed, synthesized, characterized and screened for their hMAO-A and hMAO-B inhibitory activity by an in vitro flurometric method. The enzyme inhibition assay revealed that most of the synthesized compounds have selective inhibition potency against hMAO-A. The compounds 3f and 3h showed promising hMAO-A inhibition with an IC values of 0.012 μM and 0.011 μM and significant selectivity indexes of 1214 and 1601 towards hMAO-A, respectively. The mechanism of hMAO-A inhibition of compounds 3f and 3h was investigated by Lineweaver-Burk graphics and reversible-competitive inhibition of hMAO-A was determined. Cytotoxicity and genotoxicity studies were carried out and the compound 3h was found as non-cytotoxic and non-genotoxic. Theoretical calculation of ADME properties suggested that synthesized compounds may have a good pharmacokinetic profile. The docking study of compound 3f and 3h revealed that there is a strong interaction between the active sites of hMAO-A and analyzed compound.

摘要

在最近的研究中发现,许多噻唑基肼衍生物在微摩尔浓度范围内显示出对人单胺氧化酶(hMAO)的抑制活性。因此,在本研究中,设计、合成、表征了一系列新的噻唑 - 肼类化合物(3a - 3n),并通过体外荧光法筛选它们对hMAO - A和hMAO - B的抑制活性。酶抑制试验表明,大多数合成化合物对hMAO - A具有选择性抑制效力。化合物3f和3h对hMAO - A显示出有前景的抑制作用,IC值分别为0.012 μM和0.011 μM,对hMAO - A的选择性指数分别为1214和1601。通过Lineweaver - Burk图研究了化合物3f和3h对hMAO - A的抑制机制,并确定为对hMAO - A的可逆竞争性抑制。进行了细胞毒性和遗传毒性研究,发现化合物3h无细胞毒性和遗传毒性。ADME性质的理论计算表明,合成化合物可能具有良好的药代动力学特征。化合物3f和3h的对接研究表明,hMAO - A的活性位点与分析的化合物之间存在强相互作用。

相似文献

1
Design, synthesis and biological assessment of new thiazolylhydrazine derivatives as selective and reversible hMAO-A inhibitors.新型噻唑基肼衍生物作为选择性和可逆性人单胺氧化酶-A抑制剂的设计、合成及生物学评价
Eur J Med Chem. 2018 Jan 20;144:68-81. doi: 10.1016/j.ejmech.2017.12.013. Epub 2017 Dec 6.
2
MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains.含腙和炔丙基侧链的新型苯并咪唑衍生物的单胺氧化酶(MAO)酶抑制活性
Eur J Med Chem. 2017 May 5;131:92-106. doi: 10.1016/j.ejmech.2017.03.009. Epub 2017 Mar 8.
3
Synthesis and selective human monoamine oxidase B inhibition of heterocyclic hybrids based on hydrazine and thiazole scaffolds.基于肼和噻唑骨架的杂环杂合体的合成及对人单胺氧化酶 B 的选择性抑制。
Arch Pharm (Weinheim). 2013 Jan;346(1):17-22. doi: 10.1002/ardp.201200318. Epub 2012 Oct 15.
4
Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors.噻唑烷腙骨架的研究:选择性人单胺氧化酶抑制剂的合成与分子模拟。
Bioorg Med Chem. 2010 Aug 1;18(15):5715-23. doi: 10.1016/j.bmc.2010.06.007. Epub 2010 Jun 9.
5
Design and Synthesis of New Benzothiazole Compounds as Selective hMAO-B Inhibitors.新型苯并噻唑类化合物的设计与合成及其作为选择性 hMAO-B 抑制剂的研究
Molecules. 2017 Dec 9;22(12):2187. doi: 10.3390/molecules22122187.
6
Exploring 4-substituted-2-thiazolylhydrazones from 2-, 3-, and 4-acetylpyridine as selective and reversible hMAO-B inhibitors.探索 2-、3-和 4-乙酰基吡啶的 4-取代-2-噻唑基腙作为选择性和可逆的 hMAO-B 抑制剂。
Eur J Med Chem. 2013 Aug;66:221-7. doi: 10.1016/j.ejmech.2013.05.032. Epub 2013 Jun 3.
7
Monoamine Oxidase Inhibitory Activity: Methyl- versus Chlorochalcone Derivatives.单胺氧化酶抑制活性:甲基查耳酮与氯代查耳酮衍生物
ChemMedChem. 2016 Dec 16;11(24):2649-2655. doi: 10.1002/cmdc.201600497. Epub 2016 Nov 30.
8
Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors.新型硫代卡巴肼衍生物:作为潜在 MAO-B 抑制剂的体外和计算评价。
Molecules. 2021 Nov 2;26(21):6640. doi: 10.3390/molecules26216640.
9
Recent advances in the development of selective human MAO-B inhibitors: (hetero)arylidene-(4-substituted-thiazol-2-yl)hydrazines.选择性人单胺氧化酶-B 抑制剂的最新进展:(杂)芳亚基-(4-取代-噻唑-2-基)腙。
Eur J Med Chem. 2012 Dec;58:405-17. doi: 10.1016/j.ejmech.2012.10.032. Epub 2012 Oct 26.
10
4-tert-Pentylphenoxyalkyl derivatives - Histamine H receptor ligands and monoamine oxidase B inhibitors.4-叔戊基苯氧基烷基衍生物——组胺H受体配体和单胺氧化酶B抑制剂。
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3596-3600. doi: 10.1016/j.bmcl.2018.10.048. Epub 2018 Oct 31.

引用本文的文献

1
Exploring of novel oxazolones and imidazolones as anti-inflammatory and analgesic candidates with cyclooxygenase inhibitory action.探索新型恶唑酮和咪唑酮作为具有环氧化酶抑制作用的抗炎和镇痛候选物。
Future Med Chem. 2024;16(10):963-981. doi: 10.4155/fmc-2023-0338. Epub 2024 Apr 19.
2
Design, Synthesis, and Biological Effect Studies of Novel Benzofuran-Thiazolylhydrazone Derivatives as Monoamine Oxidase Inhibitors.新型苯并呋喃-噻唑基腙衍生物作为单胺氧化酶抑制剂的设计、合成及生物学效应研究
ACS Omega. 2024 Feb 29;9(10):11388-11397. doi: 10.1021/acsomega.3c07703. eCollection 2024 Mar 12.
3
Design, Synthesis, and and Approaches of Novel Indanone Derivatives as Multifunctional Anti-Alzheimer Agents.
新型茚满酮衍生物作为多功能抗阿尔茨海默病药物的设计、合成及方法
ACS Omega. 2022 Dec 7;7(50):47378-47404. doi: 10.1021/acsomega.2c06906. eCollection 2022 Dec 20.
4
Synthesis of novel benzothiazole derivatives and investigation of their enzyme inhibitory effects against Alzheimer's disease.新型苯并噻唑衍生物的合成及其对阿尔茨海默病的酶抑制作用研究
RSC Adv. 2022 Aug 19;12(36):23626-23636. doi: 10.1039/d2ra03803j. eCollection 2022 Aug 16.
5
Rational design of biodegradable sulphonamide candidates treating septicaemia by synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme.通过协同抑制 COX-2/PGE2 轴和 DHPS 酶双重作用来治疗败血症的可生物降解磺胺类候选药物的合理设计。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1737-1751. doi: 10.1080/14756366.2022.2086868.
6
Design, synthesis, biological assessment and ADME prediction of new 2-(4-(methylsulfonyl) phenyl) benzimidazoles as selective cyclooxygenase-2 inhibitors.新型2-(4-(甲基磺酰基)苯基)苯并咪唑类作为选择性环氧合酶-2抑制剂的设计、合成、生物学评价及ADME预测
RSC Adv. 2021 Aug 17;11(44):27659-27673. doi: 10.1039/d1ra04756f. eCollection 2021 Aug 9.
7
Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors.新型硫代卡巴肼衍生物:作为潜在 MAO-B 抑制剂的体外和计算评价。
Molecules. 2021 Nov 2;26(21):6640. doi: 10.3390/molecules26216640.
8
New Amides Containing Selenium as Potent Leishmanicidal Agents Targeting Trypanothione Reductase.新型含硒酰胺类化合物作为潜在的利什曼原虫双氢叶酸还原酶抑制剂。
Antimicrob Agents Chemother. 2020 Dec 16;65(1). doi: 10.1128/AAC.00524-20.
9
Design, Synthesis, In Vitro and In Silico Studies of New Thiazolylhydrazine-Piperazine Derivatives as Selective MAO-A Inhibitors.新型噻唑基腙-哌嗪衍生物的设计、合成、体外及计算机模拟研究作为选择性 MAO-A 抑制剂。
Molecules. 2020 Sep 22;25(18):4342. doi: 10.3390/molecules25184342.
10
Synthesis, enzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective MAO-B inhibitors.新型苄胺-磺胺衍生物的合成、酶活性及分子对接研究作为选择性 MAO-B 抑制剂。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1422-1432. doi: 10.1080/14756366.2020.1784892.